tiprankstipranks
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
US Market
MLYS
Mineralys Therapeutics, Inc.
RESEARCH TOOLSreports

Mineralys Therapeutics, Inc. (MLYS) Financial Statements

Compare
590 Followers

Mineralys Therapeutics, Inc. Financial Overview

Mineralys Therapeutics, Inc.'s market cap is currently $1.95B. The company's EPS TTM is $-0.4; its P/E ratio is -22.67; Mineralys Therapeutics, Inc. is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.48. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -59.00K$ -43.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -170.60M$ -192.40M$ -84.66M$ -31.48M$ -18.73M
EBITDA$ -170.60M$ -192.36M$ -84.66M$ -31.48M$ -19.38M
Net Income$ -154.65M$ -177.81M$ -71.90M$ -29.80M$ -19.41M
Balance Sheet
Cash & Short-Term Investments$ 656.63M$ 198.19M$ 236.57M$ 110.11M$ 10.61M
Total Assets$ 661.81M$ 205.90M$ 251.64M$ 114.44M$ 11.13M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -172.92M$ -114.09M$ -49.30M$ -87.70M$ -10.61M
Total Liabilities$ 15.11M$ 14.65M$ 10.48M$ 166.71M$ 34.05M
Stockholders' Equity$ 646.69M$ 191.26M$ 241.15M$ -52.27M$ -22.93M
Cash Flow
Free Cash Flow$ -142.43M$ -166.41M$ -81.17M$ -29.22M$ -14.56M
Operating Cash Flow$ -142.42M$ -166.31M$ -81.17M$ -29.22M$ -14.56M
Investing Cash Flow$ -389.75M$ 114.96M$ -160.47M$ -21.76M$ 0.00
Financing Cash Flow$ 591.00M$ 116.14M$ 203.25M$ 128.02M$ 23.81M
Currency in USD

Mineralys Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Mineralys Therapeutics, Inc. Debt to Assets

Balance Sheet >

Mineralys Therapeutics, Inc. Cash Flow

Cash Flow >

Mineralys Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >